Literature DB >> 15710711

Giant cell arteritis and cardiovascular disease in older adults.

J G Ray1, M M Mamdani, W H Geerts.   

Abstract

OBJECTIVE: To explore the association between giant cell arteritis (GCA) and subsequent cardiovascular disease in older adults.
DESIGN: Population based retrospective cohort study.
SETTING: The entire province of Ontario, Canada. PARTICIPANTS: Patients aged 66 years and older with newly diagnosed GCA (n = 1141), osteoarthritis (n = 172,953), or neither (n = 200,000). Patients with neither were randomly selected from the general population and formed the control group. MAIN OUTCOME MEASURES: The primary composite outcome was based on a subsequent diagnosis or surgical treatment for coronary artery disease, stroke, peripheral arterial disease, or aneurysm or dissection of the aorta.
RESULTS: The composite end point was more common in seniors with GCA (12.1/1000 person-years) than in patients with osteoarthritis (7.3/1000 person-years) or neither condition (5.3/1000 person-years). The adjusted hazard ratio for cardiovascular disease was 1.6 (95% confidence interval (CI) 1.1 to 2.2) in patients with GCA versus patients with osteoarthritis, and 2.1 (95% CI 1.5 to 3.0) in patients with GCA versus unaffected controls.
CONCLUSIONS: Older adults with GCA appear to be at increased risk for developing cardiovascular disease. Whether an aggressive approach to cardiovascular risk factor modification is particularly beneficial in these patients remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710711      PMCID: PMC1768751          DOI: 10.1136/hrt.2004.037481

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  40 in total

1.  Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.

Authors:  F Puisieux; P de Groote; E Masy; C Di Pompeo; A Millaire; O Bouillanne; B Jude; P Dewailly; G Ducloux
Journal:  Am J Med       Date:  2000-12-01       Impact factor: 4.965

2.  Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis.

Authors:  E Hachulla; V Boivin; U Pasturel-Michon; A L Fauchais; J Bouroz-Joly; M Perez-Cousin; P Y Hatron; B Devulder
Journal:  Clin Exp Rheumatol       Date:  2001 Mar-Apr       Impact factor: 4.473

3.  Increment of the platelet count in temporal arteritis: response to therapy and ischemic complications.

Authors:  P Gonzalez-Alegre; A D Ruiz-Lopez; M Abarca-Costalago; P Gonzalez-Santos
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

4.  Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey.

Authors:  Gurkirpal Singh; Jeffrey D Miller; Fleur H Lee; Dan Pettitt; Mason W Russell
Journal:  Am J Manag Care       Date:  2002-10       Impact factor: 2.229

5.  Lower limb giant cell arteritis and temporal arteritis: followup of 8 cases.

Authors:  C Le Hello; H Lévesque; M Jeanton; N Cailleux; F Galateau; C Peillon; P Veyssier; J Watelet; P Letellier; H Courtois; D Maïza
Journal:  J Rheumatol       Date:  2001-06       Impact factor: 4.666

6.  Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells.

Authors:  A D Wagner; H C Gérard; T Fresemann; W A Schmidt; E Gromnica-Ihle; A P Hudson; H Zeidler
Journal:  Arthritis Rheum       Date:  2000-07

7.  Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity.

Authors:  S Tuhrim; J H Rand; X X Wu; J Weinberger; D R Horowitz; M E Goldman; J H Godbold
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

8.  Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study.

Authors:  M S Elkind; I F Lin; J T Grayston; R L Sacco
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

Review 9.  Neurologic manifestations of giant cell arteritis.

Authors:  G Nesher
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

Review 10.  Spectrum of giant cell vasculitis.

Authors:  N Mohan; G Kerr
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

View more
  14 in total

1.  Hospitalization rates and utilization among patients with giant cell arteritis: A population-based study from 1987 to 2012.

Authors:  Clement John Michet; Sara J Achenbach; Cynthia S Crowson; Eric L Matteson
Journal:  Semin Arthritis Rheum       Date:  2015-03-03       Impact factor: 5.532

2.  Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia.

Authors:  Shubhasree Banerjee; Mohammadhadi Bagheri; Veit Sandfort; Mark A Ahlman; Ashkan A Malayeri; David A Bluemke; Jianhua Yao; Peter C Grayson
Journal:  Semin Arthritis Rheum       Date:  2018-09-17       Impact factor: 5.532

3.  [Managing comorbidities of inflammatory rheumatic diseases].

Authors:  K de Groot; E Märker-Hermann
Journal:  Internist (Berl)       Date:  2011-06       Impact factor: 0.743

Review 4.  Visual loss and other cranial ischaemic complications in giant cell arteritis.

Authors:  Alessandra Soriano; Francesco Muratore; Nicolò Pipitone; Luigi Boiardi; Luca Cimino; Carlo Salvarani
Journal:  Nat Rev Rheumatol       Date:  2017-07-06       Impact factor: 20.543

Review 5.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

6.  Coronary artery stenting in acute coronary syndrome associated with giant cell arteritis.

Authors:  Lillian Armellin; Anthony Michael Sammel; Ben Ng; Kiran Sarathy; John Lambros; Taraneh Amir-Nezami; Shannon Dean Thomas; John Highton; Arvin Damodaran
Journal:  J Cardiol Cases       Date:  2017-06-27

7.  Current diagnosis and treatment of temporal arteritis.

Authors:  Wolfgang A Schmidt
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

8.  Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.

Authors:  Gunnar Tomasson; Christine Peloquin; Aladdin Mohammad; Thorvardur J Love; Yuqing Zhang; Hyon K Choi; Peter A Merkel
Journal:  Ann Intern Med       Date:  2014-01-21       Impact factor: 25.391

9.  Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study.

Authors:  Prabhu D Udayakumar; Arun K Chandran; Cynthia S Crowson; Kenneth J Warrington; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-03       Impact factor: 4.794

10.  Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.

Authors:  Mar Pujades-Rodriguez; Bram Duyx; Sara L Thomas; Dimitris Stogiannis; Liam Smeeth; Harry Hemingway
Journal:  Heart       Date:  2016-01-19       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.